# Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

> **NCT01087268** · PHASE3 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 75 (estimated)

## Conditions studied

- Bladder Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Gastrointestinal Complications
- Long-term Effects Secondary to Cancer Therapy in Adults
- Ovarian Cancer
- Prostate Cancer
- Radiation Toxicity
- Sarcoma
- Testicular Germ Cell Tumor
- Vaginal Cancer

## Interventions

- **OTHER:** questionnaire administration
- **PROCEDURE:** gastrointestinal complications management/prevention
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01087268
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2011-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087268, "Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01087268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*